Ya-jia Xie

Dr. Neher's Biophysics Laboratory For Innovative Drug Discovery, State Key Laboratory Of Quality Research In Chinese Medicine, Avenida Wai Long
Macao, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Depletion of regulatory T cells enhancing the anti-tumor effect of in situ vaccination in solid tumors.

Depletion of regulatory T cells enhancing the anti-tumor effect of in situ vaccination in solid tumors.

Journal: Pharmacological research

Published: July 09, 2023

β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer.

β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer.

Journal: Pharmacological research

Published: January 02, 2023

Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor.

Overcoming Suppressive Tumor Microenvironment by Vaccines in Solid Tumor.

Journal: Vaccines

Published: December 31, 2022

Tumor PKCδ instigates immune exclusion in EGFR-mutated non-small cell lung cancer.

Tumor PKCδ instigates immune exclusion in EGFR-mutated non-small cell lung cancer.

Journal: BMC medicine

Published: August 02, 2022

Bacteria-based nanodrug for anticancer therapy.

Bacteria-based nanodrug for anticancer therapy.

Journal: Pharmacological research

Published: March 25, 2022

PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy.

PA-MSHA induces inflamed tumor microenvironment and sensitizes tumor to anti-PD-1 therapy.

Journal: Cell death & disease

Published: March 16, 2022

Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response.

Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response.

Journal: Pharmacological research

Published: February 26, 2022

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer.

Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer.

Journal: Cancer letters

Published: March 22, 2021

Pyronaridine induces apoptosis in non-small cell lung cancer cells by upregulating death receptor 5 expression and inhibiting epidermal growth factor receptor.

Pyronaridine induces apoptosis in non-small cell lung cancer cells by upregulating death receptor 5 expression and inhibiting epidermal growth factor receptor.

Journal: Chemical biology & drug design

Published: March 13, 2021

Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells.

Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells.

Journal: Pharmacological research

Published: March 09, 2021

Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis.

Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 14, 2020

Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway.

Dolutegravir derivative inhibits proliferation and induces apoptosis of non-small cell lung cancer cells via calcium signaling pathway.

Journal: Pharmacological research

Published: July 04, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026